Martin Lepšík IOCB AS CRJindřich Fanfrlík IOCB AS CRKarel Berka UPOLPavel Polishchuk UPOLAttendance of the event is free of charge. Lecture room holds up to 36 seats.Program starts on Monday 30 January 2017 at 13 hLectures (1,5 h each)Drug design introduction (Berka)Chemical libraries (Polishchuk)Properties of biologically active compounds (Fanfrlik)Ligand-based methods (QSAR and Pharmacophore) (Polishchuk)Molecular docking and scoring (Berka)Advanced docking (Fanfrlík)MM,MD (Lepšík)Advanced scoring (Lepšík)Advanced Virtual Screening (Fanfrlík)Training (2,5 h each)QSAR (Polishchuk)Pharmacophore (Polishchuk)Molecular docking (Berka)Advanced molecular docking (Lepsik, Fanfrlik)Registration is closed.If you have any questions, please send them to [email protected]
5ADD workshop/challenge (3.2.-7.2.2020) is focused on the use of in silico drug design tools and approaches in the drug design. We will cover both structure-based drug design (molecular docking, molecular dynamics, structural bioinformatics tools) and
projít na článekWorkshop on advanced in silico drug design ligand-based (QSAR, pharmacophores) and structure-based (molecular modelling, molecular docking).Advanced in silico drug design workshopKarel Berka UPOLPavlo Polishchuk UPOLJana Vrbková UPOLMartin Lepšík IOC
projít na článek4ADD workshop/hackathon (21.1.-25.1.2019) is focused on the use of in silico drug design tools and approaches in the drug design and optimization. Workshop will cover both structure-based drug design (molecular docking, molecular dynamics, structural bioi
projít na článekShort ELIXIR CZ workshop about in silico drug design.Karel BerkaJindřich FanfrlíkMartin LepšíkProgram (KFC/ADD 4 ECTS credits)Monday 1.2.201613:00 Drug design – intro (Berka)14:00 Databases of small molecules (ZINC), drug representations (Berka)1
projít na článek6ADD workshop/challenge (30.1.-3.2.2023) is focused on using in silico tools and approaches in drug design. We will cover both structure-based drug design (molecular docking, molecular dynamics, structural bioinformatics tools) and ligand-based drug desig
projít na článek